Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Michel

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Physical Review. E|August 1, 2025
Sequential spin-logic algorithmics for Ising machinesLaura Michel, Marco Rogier, Frédéric Lechenault
Natural Product Research|November 28, 2006
Antimicrobial and antioxidant activities of the methanolic extracts of three Salvia species from TunisiaKarima Bel Hadj Salah, Mohamed Ali Mahjoub, Samia Ammar, et al.
Breast Cancer Research and Treatment|August 21, 2020
Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomyFabian Riedel, Joerg Heil, Manuel Feisst, et al.
JCO Clinical Cancer Informatics|December 23, 2024
Machine Learning to Predict the Individual Risk of Treatment-Relevant Toxicity for Patients With Breast Cancer Undergoing Neoadjuvant Systemic TreatmentLie Cai, Thomas M Deutsch, Chris Sidey-Gibbons, et al.
Archives of Gynecology and Obstetrics|February 9, 2017
Impact of reproductive factors on breast cancer subtypes in postmenopausal women: a retrospective single-center studyAlexandra von Au, Mona Klotzbuecher, Lorenz Uhlmann, et al.
International Journal of Molecular Sciences|September 9, 2022
Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic TreatmentChiara Fischer, Andrey Turchinovich, Manuel Feisst, et al.
Oncology Research and Treatment|November 28, 2024
HER2(-Low) Expression on Circulating Tumor Cells and Corresponding Metastatic Tissue in Metastatic Breast CancerLara M Tretschock, Hannah Clemente, Katharina Smetanay, et al.
Archives of Gynecology and Obstetrics|August 18, 2022
Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancerAlexandra von Au, Samra Shencoru, Lorenz Uhlmann, et al.
Archives of Gynecology and Obstetrics|March 3, 2022
Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancerChiara Fischer, Thomas M Deutsch, Manuel Feisst, et al.
Cancers|December 9, 2020
Adjuvant Radiation Therapy for Male Breast Cancer-A Rare Indication?Tobias Forster, Clara Köhler, Rami El Shafie, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Physical Review. E|August 1, 2025
Sequential spin-logic algorithmics for Ising machinesLaura Michel, Marco Rogier, Frédéric Lechenault
Natural Product Research|November 28, 2006
Antimicrobial and antioxidant activities of the methanolic extracts of three Salvia species from TunisiaKarima Bel Hadj Salah, Mohamed Ali Mahjoub, Samia Ammar, et al.
Breast Cancer Research and Treatment|August 21, 2020
Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomyFabian Riedel, Joerg Heil, Manuel Feisst, et al.
JCO Clinical Cancer Informatics|December 23, 2024
Machine Learning to Predict the Individual Risk of Treatment-Relevant Toxicity for Patients With Breast Cancer Undergoing Neoadjuvant Systemic TreatmentLie Cai, Thomas M Deutsch, Chris Sidey-Gibbons, et al.
Archives of Gynecology and Obstetrics|February 9, 2017
Impact of reproductive factors on breast cancer subtypes in postmenopausal women: a retrospective single-center studyAlexandra von Au, Mona Klotzbuecher, Lorenz Uhlmann, et al.
International Journal of Molecular Sciences|September 9, 2022
Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic TreatmentChiara Fischer, Andrey Turchinovich, Manuel Feisst, et al.
Oncology Research and Treatment|November 28, 2024
HER2(-Low) Expression on Circulating Tumor Cells and Corresponding Metastatic Tissue in Metastatic Breast CancerLara M Tretschock, Hannah Clemente, Katharina Smetanay, et al.
Archives of Gynecology and Obstetrics|August 18, 2022
Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancerAlexandra von Au, Samra Shencoru, Lorenz Uhlmann, et al.
Archives of Gynecology and Obstetrics|March 3, 2022
Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancerChiara Fischer, Thomas M Deutsch, Manuel Feisst, et al.
Cancers|December 9, 2020
Adjuvant Radiation Therapy for Male Breast Cancer-A Rare Indication?Tobias Forster, Clara Köhler, Rami El Shafie, et al.
Pageof 3